This service uses data-driven assessments of Site capabilities, resources, and patient populations to identify the most viable study locations and align protocols accordingly.

For Sites, it improves their chances of selection by highlighting their strengths and matching them with appropriate trials.

For Sponsors and CROs, it reduces startup delays and enrollment risks by ensuring the right Sites are chosen from the outset.